Rosiello Limited – Trademark Portfolio

Entity Type: 03

Rosiello Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LUMITY. The owner is based in 1060 Nicosia.

Afroditis 25, 2nd Floor Office 204

1060 Nicosia , CY

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUMITY
LUMITY
Registered 2016
LUMITY
LUMITY
Registered 2015

Trademark Classifications

Rosiello Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Rosiello Limited have?

Rosiello Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Rosiello Limited file in?

Rosiello Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Rosiello Limited's most well-known trademarks?

Rosiello Limited's registered trademark portfolio includes well-known marks such as LUMITY. These are among 2 currently registered trademarks in the portfolio.

What is Rosiello Limited's trademark registration success rate?

Rosiello Limited has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.